Evidence map›Paper›PMID 34458011›Full record

ArticleMolecular therapy. Nucleic acids2021

Lentiviral vectors transduce lung stem cells without disrupting plasticity.

Ashley L Cooney, Andrew L Thurman, Paul B McCray, Alejandro A Pezzulo, Patrick L Sinn

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 14 citations in OpenAlex.

  1. Lentiviral-mediated gene complementation to rescue pathogenic ABCA3 variants.American journal of respiratory cell and molecular biology · 2026
    Article
  2. Optimized AAV capsids robustly transduce airway epithelial cells.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Lentiviral-mediated gene complementation rescues pathogenicbioRxiv : the preprint server for biology · 2025
    Article
  6. CF airway epithelia display exaggerated host defense responses and prolonged cilia loss during RSV infection.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2025
    Article
  7. Article
  8. Article
  9. Lentiviral Gene Therapy for Cystic Fibrosis: A Promising Approach and First-in-Human Trial.American journal of respiratory and critical care medicine · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ashley L CooneyStead Family Department of Pediatrics, The University of Iowa, Department of Pediatrics, 169 Newton RD, 6320 PBDB, Iowa City, IA 52242, USA.
Andrew L ThurmanPappajohn Biomedical Institute and the Center for Gene Therapy, The University of Iowa, Iowa City, IA 52242, USA.
Paul B McCrayStead Family Department of Pediatrics, The University of Iowa, Department of Pediatrics, 169 Newton RD, 6320 PBDB, Iowa City, IA 52242, USA.
Alejandro A PezzuloPappajohn Biomedical Institute and the Center for Gene Therapy, The University of Iowa, Iowa City, IA 52242, USA.
Patrick L SinnStead Family Department of Pediatrics, The University of Iowa, Department of Pediatrics, 169 Newton RD, 6320 PBDB, Iowa City, IA 52242, USA.
University of Iowa · US

Funding

Vector CoreP01HL051670 · NHLBI · UNIVERSITY OF IOWA · PI ENGELHARDT, JOHN F · 1993 to 2019
$36.5M
Respiratory virus infection in early cystic fibrosis lung diseaseP01HL091842 · NHLBI · UNIVERSITY OF IOWA · PI ZABNER, JOSEPH · 2008 to 2022
$34.2M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Amy Leanne Ryan · 1998 to 2026
$30.5M
Pathology CoreP01HL152960 · NHLBI · UNIVERSITY OF IOWA · PI ENGELHARDT, JOHN F · 2020 to 2024
$11.6M
Life-long phenotypic correction of CF airwaysR01HL133089 · NHLBI · UNIVERSITY OF IOWA · PI PATRICK L SINN · 2017 to 2026
$5.3M
Heat-shock protein 90 modulates goblet cell metaplasia in human airway epitheliaK01HL140261 · NHLBI · UNIVERSITY OF IOWA · PI PEZZULO, ALEJANDRO ANTONIO · 2019 to 2023
$746k
NHLBI NIH HHS K01 HL140261NHLBI NIH HHS P01 HL051670NHLBI NIH HHS P01 HL091842NHLBI NIH HHS P01 HL152960NHLBI NIH HHS R01 HL133089NIDDK NIH HHS P30 DK054759
6 · The paper itself

Abstract

Life-long expression of a gene therapy agent likely requires targeting stem cells. Here we ask the question: does viral vector transduction or ectopic expression of a therapeutic transgene preclude airway stem cell function? We used a lentiviral vector containing a GFP or cystic fibrosis transmembrane conductance regulator (

Indexed as

basal cellsCFTRcystic fibrosisgene therapylentivirus

Identifiers

PMID34458011
PMCPMC8379527
OpenAlexW3173593974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.